195 related articles for article (PubMed ID: 19457579)
1. Investigation on the anti-tumor efficacy by expression of GPI-anchored mIL-21 on the surface of B16F10 cells in C57BL/6 mice.
Zhao F; Dou J; Wang J; Chu L; Tang Q; Wang Y; Li Y; Cao M; Hu W; Hu K; Feng He X; Gu N
Immunobiology; 2010; 215(2):89-100. PubMed ID: 19457579
[TBL] [Abstract][Full Text] [Related]
2. Enhancing therapy of B16F10 melanoma efficacy through tumor vaccine expressing GPI-anchored IL-21 and secreting GM-CSF in mouse model.
Zhao F; Dou J; He XF; Wang J; Chu L; Hu W; Yu F; Hu K; Wu Y; Gu N
Vaccine; 2010 Apr; 28(16):2846-52. PubMed ID: 20153795
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of murine Lewis lung cancer with recombinant interleukin-12].
Yin XL; Duan H; Peng ZP; Sun SL; Li SL
Ai Zheng; 2006 Sep; 25(9):1087-91. PubMed ID: 16965647
[TBL] [Abstract][Full Text] [Related]
4. Glycolipid-anchored IL-12 expressed on tumor cell surface induces antitumor immune response.
Nagarajan S; Selvaraj P
Cancer Res; 2002 May; 62(10):2869-74. PubMed ID: 12019166
[TBL] [Abstract][Full Text] [Related]
5. Regulation gene expression of miR200c and ZEB1 positively enhances effect of tumor vaccine B16F10/GPI-IL-21 on inhibition of melanoma growth and metastasis.
Wang X; He X; Zhao F; Wang J; Zhang H; Shi F; Zhang Y; Cai K; Dou J
J Transl Med; 2014 Mar; 12():68. PubMed ID: 24625224
[TBL] [Abstract][Full Text] [Related]
6. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
[TBL] [Abstract][Full Text] [Related]
7. Preliminary study on mouse interleukin-21 application in tumor gene therapy.
Dou J; Chen G; Wang J; Zhao F; Chen J; Fang X; Tang Q; Chu L
Cell Mol Immunol; 2004 Dec; 1(6):461-6. PubMed ID: 16293216
[TBL] [Abstract][Full Text] [Related]
8. ESAT-6-gpi DNA vaccine augmented the specific antitumour efficacy induced by the tumour vaccine B16F10-ESAT-6-gpi/IL-21 in a mouse model.
He X; Wang J; Zhao F; Chen D; Chen J; Zhang H; Yang C; Liu Y; Dou J
Scand J Immunol; 2013 Jul; 78(1):69-78. PubMed ID: 23679337
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy of melanoma by GPI-anchored IL-21 tumour vaccine involves down-regulating regulatory T cells in mouse model.
Wang J; Zhao F; Dou J; He XF; Chu L; Cao M; Liu C; Li Y; Gu N
Int J Immunogenet; 2011 Feb; 38(1):21-9. PubMed ID: 20727044
[TBL] [Abstract][Full Text] [Related]
10. Human tumor membrane vesicles modified to express glycolipid-anchored IL-12 by protein transfer induce T cell proliferation in vitro: a potential approach for local delivery of cytokines during vaccination.
Nagarajan S; Selvaraj P
Vaccine; 2006 Mar; 24(13):2264-74. PubMed ID: 16376465
[TBL] [Abstract][Full Text] [Related]
11. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
[TBL] [Abstract][Full Text] [Related]
12. Gene therapy with interleukin-10 receptor and interleukin-12 induces a protective interferon-γ-dependent response against B16F10-Nex2 melanoma.
Marchi LH; Paschoalin T; Travassos LR; Rodrigues EG
Cancer Gene Ther; 2011 Feb; 18(2):110-22. PubMed ID: 20885448
[TBL] [Abstract][Full Text] [Related]
13. Significant antitumor effects obtained by autologous tumor cell vaccine engineered to secrete interleukin (IL)-12 and IL-18 by means of the EBV/lipoplex.
Asada H; Kishida T; Hirai H; Satoh E; Ohashi S; Takeuchi M; Kubo T; Kita M; Iwakura Y; Imanishi J; Mazda O
Mol Ther; 2002 May; 5(5 Pt 1):609-16. PubMed ID: 11991752
[TBL] [Abstract][Full Text] [Related]
14. A novel anticancer approach: SEA-anchored tumor cells expressing heat shock protein 70 onto the surface elicit strong anticancer efficacy.
Huang C; Yu H; Wang Q; Yang G; Ma W; Xia D; Chen X; Yi P; Shen F; Zheng H; Cao X
Immunol Lett; 2005 Oct; 101(1):71-80. PubMed ID: 15908014
[TBL] [Abstract][Full Text] [Related]
15. Genetic immunization with GPI-anchored anthrax protective antigen raises combined CD1d- and MHC II-restricted antibody responses by natural killer T cell-mediated help.
Midha S; Bhatnagar R
Vaccine; 2009 Mar; 27(11):1700-9. PubMed ID: 19195490
[TBL] [Abstract][Full Text] [Related]
16. Reinforcing B16F10/GPI-IL-21 vaccine efficacy against melanoma by injecting mice with shZEB1 plasmid or miR200c agomir.
Wang X; Zhao F; Shi F; He X; Pan M; Wu D; Li M; Zhang Y; Dou J
Biomed Pharmacother; 2016 May; 80():136-144. PubMed ID: 27133050
[TBL] [Abstract][Full Text] [Related]
17. Synergistic anti-tumor effect of glycosylphosphatidylinositol-anchored IL-2 and IL-12.
Ji J; Li J; Holmes LM; Burgin KE; Yu X; Wagner TE; Wei Y
J Gene Med; 2004 Jul; 6(7):777-85. PubMed ID: 15241785
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-23 and interleukin-27 exert quite different antitumor and vaccine effects on poorly immunogenic melanoma.
Oniki S; Nagai H; Horikawa T; Furukawa J; Belladonna ML; Yoshimoto T; Hara I; Nishigori C
Cancer Res; 2006 Jun; 66(12):6395-404. PubMed ID: 16778218
[TBL] [Abstract][Full Text] [Related]
19. Investigation of GM-CSF immune accessory effects in tumor-bearing mice by direct gene immunization.
Dou J; Hong X; Zhao F; Wang J; Chen J; Chen G
Immunol Invest; 2006; 35(2):227-37. PubMed ID: 16698679
[TBL] [Abstract][Full Text] [Related]
20. Tumor-associated antigen/IL-21-transduced dendritic cell vaccines enhance immunity and inhibit immunosuppressive cells in metastatic melanoma.
Aravindaram K; Wang PH; Yin SY; Yang NS
Gene Ther; 2014 May; 21(5):457-67. PubMed ID: 24572790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
